Literature DB >> 22129054

The creation and progress of the J Project in Eastern and Central Europe.

László Maródi1.   

Abstract

Primary immunodeficiencies (PIDs) have now become recognized as a worldwide health problem. Rapid development of immunological and genetic technologies has led to the discovery of more than 200 PIDs and more than 150 disease-related genes. Progress in the field is expected to take a new turn after the introduction of new-generation sequencing technologies that will enable searches for currently unknown PID-related genes. By contrast, even with progress in molecular genetics, many patients remain ill and die early because of the lack of diagnostic or treatment facilities, or both. Thus, the gap between the knowledge accumulated and the appropriate management of patients with PIDs in everyday clinical practice has widened, necessitating PID awareness, particularly in countries with poor socioeconomic conditions. The J Project, established as a physician education and research collaboration program in Eastern and Central Europe, demonstrates how professional responsibility and long-term joint efforts can make a beneficial difference for patients with inborn errors of immunity.
© 2011 New York Academy of Sciences.

Entities:  

Mesh:

Year:  2011        PMID: 22129054     DOI: 10.1111/j.1749-6632.2011.06247.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  7 in total

1.  Collaborating to improve quality of life in primary immunodeficiencies: World PI Week, 2013.

Authors:  Ricardo Sorensen; Amos Etzioni; Ahmed Aziz Bousfiha; John B Zeiger
Journal:  J Clin Immunol       Date:  2013-07-11       Impact factor: 8.317

2.  Fifteen Years of the J Project.

Authors:  László Maródi
Journal:  J Clin Immunol       Date:  2019-05-17       Impact factor: 8.317

Review 3.  The spread of the J Project.

Authors:  Zsuzsa Horváth; Nima Rezaei; Ismail Reisli; Irina Tuzankina; Nurzhan Otarbayev; Panteley Popandopulo; László Maródi
Journal:  J Clin Immunol       Date:  2013-05-19       Impact factor: 8.317

4.  Comprehensive genetic testing for primary immunodeficiency disorders in a tertiary hospital: 10-year experience in Auckland, New Zealand.

Authors:  See-Tarn Woon; Rohan Ameratunga
Journal:  Allergy Asthma Clin Immunol       Date:  2016-12-07       Impact factor: 3.406

5.  New and recurrent gain-of-function STAT1 mutations in patients with chronic mucocutaneous candidiasis from Eastern and Central Europe.

Authors:  Beáta Soltész; Beáta Tóth; Nadejda Shabashova; Anastasia Bondarenko; Satoshi Okada; Sophie Cypowyj; Avinash Abhyankar; Gabriella Csorba; Szilvia Taskó; Adrien Katalin Sarkadi; Leonóra Méhes; Pavel Rozsíval; David Neumann; Liudmyla Chernyshova; Zsolt Tulassay; Anne Puel; Jean-Laurent Casanova; Anna Sediva; Jiri Litzman; László Maródi
Journal:  J Med Genet       Date:  2013-05-24       Impact factor: 6.318

6.  Ensuring Access to Immunoglobulin Therapies for People with Primary Immunodeficiency: A Need to Improve Individuals' Quality of Life and the Sustainability of Health-care Systems.

Authors:  Ahmed Aziz Bousfiha; Carla Duff; Elena Hsieh
Journal:  Front Immunol       Date:  2017-09-19       Impact factor: 7.561

7.  Recurrent, Severe Aphthous Stomatitis and Mucosal Ulcers as Primary Manifestations of a Novel STAT1 Gain-of-Function Mutation.

Authors:  Melinda Erdős; Eszter Jakobicz; Beáta Soltész; Beáta Tóth; Zsuzsanna Bata-Csörgő; László Maródi
Journal:  Front Immunol       Date:  2020-05-28       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.